Clinical trial
Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs…
NCT00412854 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00412854 |
|---|---|
| Title | Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib. |
| Official title | Phase IIIb, Multicentre Study to Assess Safety & Immunogenicity of GSK Biologicals' Combined DTPa/Hib (Infanrix/Hib) Vaccine vs Separate Administration of DTPa (Infanrix) & Hib (Hiberix) Vaccines in Healthy Infants 3,4,&5 Months of Age as Compared With the Separate Administration of DTPa and Hib… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Tetanus, Diphtheria, Acellular Pertussis |
| Intervention type | Biological |
| Interventions | Infanrix™/Hib, Infanrix, Hiberix |
| Enrollment | 660 |
| Start date | Jan 3, 2007 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 25, 2007 |
| First posted | Dec 19, 2006 |
| Last update posted | Jun 6, 2018 |
| Countries | China |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: